

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein activation cascade (GO:0072376) | 9.86418199 |
| 2 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 8.82583389 |
| 3 | Fc-gamma receptor signaling pathway (GO:0038094) | 8.82583389 |
| 4 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 8.82583389 |
| 5 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 8.70455821 |
| 6 | retina homeostasis (GO:0001895) | 7.78737652 |
| 7 | positive regulation of respiratory burst (GO:0060267) | 7.73252486 |
| 8 | humoral immune response (GO:0006959) | 7.39339158 |
| 9 | glomerular filtration (GO:0003094) | 7.18875514 |
| 10 | negative regulation of B cell proliferation (GO:0030889) | 6.66834643 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.51920848 |
| 12 | renal filtration (GO:0097205) | 6.51389436 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.44961041 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.44961041 |
| 15 | positive regulation of Rho protein signal transduction (GO:0035025) | 6.35709237 |
| 16 | positive regulation of B cell differentiation (GO:0045579) | 5.80275408 |
| 17 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.64628353 |
| 18 | regulation of respiratory burst (GO:0060263) | 5.47036854 |
| 19 | negative regulation of glucose import (GO:0046325) | 5.31635183 |
| 20 | L-fucose catabolic process (GO:0042355) | 5.18795431 |
| 21 | fucose catabolic process (GO:0019317) | 5.18795431 |
| 22 | L-fucose metabolic process (GO:0042354) | 5.18795431 |
| 23 | B cell receptor signaling pathway (GO:0050853) | 5.11821386 |
| 24 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.10945317 |
| 25 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.86165796 |
| 26 | regulation of B cell differentiation (GO:0045577) | 4.82267846 |
| 27 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.78974326 |
| 28 | regulation of B cell proliferation (GO:0030888) | 4.50123359 |
| 29 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.48380008 |
| 30 | negative regulation of glucose transport (GO:0010829) | 4.36783156 |
| 31 | positive regulation of Rap GTPase activity (GO:0032854) | 4.34368897 |
| 32 | intestinal epithelial cell development (GO:0060576) | 4.04574573 |
| 33 | signal peptide processing (GO:0006465) | 4.04566193 |
| 34 | cellular response to zinc ion (GO:0071294) | 4.03693784 |
| 35 | maternal placenta development (GO:0001893) | 3.97006918 |
| 36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.93789068 |
| 37 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.92650360 |
| 38 | bone resorption (GO:0045453) | 3.86304982 |
| 39 | positive regulation of nuclease activity (GO:0032075) | 3.79288596 |
| 40 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.76115245 |
| 41 | mannose metabolic process (GO:0006013) | 3.74570572 |
| 42 | negative regulation of osteoclast differentiation (GO:0045671) | 3.74444210 |
| 43 | regulation of Rap GTPase activity (GO:0032317) | 3.69773985 |
| 44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.69213053 |
| 45 | germinal center formation (GO:0002467) | 3.64375777 |
| 46 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.60885293 |
| 47 | apoptotic cell clearance (GO:0043277) | 3.60821549 |
| 48 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.60199728 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.58908800 |
| 50 | regulation of cellular extravasation (GO:0002691) | 3.58247903 |
| 51 | Fc receptor signaling pathway (GO:0038093) | 3.57682599 |
| 52 | regulation of nuclease activity (GO:0032069) | 3.57125718 |
| 53 | N-acetylneuraminate metabolic process (GO:0006054) | 3.54447913 |
| 54 | detection of bacterium (GO:0016045) | 3.52781403 |
| 55 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.51758009 |
| 56 | detection of other organism (GO:0098543) | 3.51585428 |
| 57 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.50067466 |
| 58 | peptidyl-asparagine modification (GO:0018196) | 3.48078698 |
| 59 | chronic inflammatory response (GO:0002544) | 3.47848315 |
| 60 | cellular response to unfolded protein (GO:0034620) | 3.46437949 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 3.45063898 |
| 62 | negative regulation of cell killing (GO:0031342) | 3.44051186 |
| 63 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.44051186 |
| 64 | type I interferon signaling pathway (GO:0060337) | 3.42960325 |
| 65 | cellular response to type I interferon (GO:0071357) | 3.42960325 |
| 66 | response to type I interferon (GO:0034340) | 3.40909369 |
| 67 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.40348816 |
| 68 | immune response-activating signal transduction (GO:0002757) | 3.39521870 |
| 69 | antibacterial humoral response (GO:0019731) | 3.38526689 |
| 70 | regulation of antigen processing and presentation (GO:0002577) | 3.36375099 |
| 71 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.35850320 |
| 72 | negative regulation of B cell activation (GO:0050869) | 3.33553031 |
| 73 | Fc-epsilon receptor signaling pathway (GO:0038095) | 3.31222136 |
| 74 | antimicrobial humoral response (GO:0019730) | 3.30081456 |
| 75 | mature B cell differentiation (GO:0002335) | 3.26946084 |
| 76 | COPI coating of Golgi vesicle (GO:0048205) | 3.26502818 |
| 77 | Golgi transport vesicle coating (GO:0048200) | 3.26502818 |
| 78 | protein N-linked glycosylation (GO:0006487) | 3.24528412 |
| 79 | positive regulation of antigen processing and presentation (GO:0002579) | 3.23790696 |
| 80 | ER-nucleus signaling pathway (GO:0006984) | 3.22805309 |
| 81 | serine transport (GO:0032329) | 3.20748927 |
| 82 | nerve growth factor signaling pathway (GO:0038180) | 3.19748382 |
| 83 | positive regulation of histone deacetylation (GO:0031065) | 3.19175397 |
| 84 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.13835697 |
| 85 | negative regulation of complement activation (GO:0045916) | 3.12300345 |
| 86 | response to endoplasmic reticulum stress (GO:0034976) | 3.11905604 |
| 87 | cellular response to topologically incorrect protein (GO:0035967) | 3.10519430 |
| 88 | activation of immune response (GO:0002253) | 3.07882091 |
| 89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.06239262 |
| 90 | L-serine transport (GO:0015825) | 3.03959560 |
| 91 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.02532742 |
| 92 | regulation of B cell activation (GO:0050864) | 2.99827219 |
| 93 | positive regulation of immunoglobulin production (GO:0002639) | 2.97645404 |
| 94 | regulation of integrin activation (GO:0033623) | 2.97542196 |
| 95 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95948207 |
| 96 | N-glycan processing (GO:0006491) | 2.90058613 |
| 97 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.88215890 |
| 98 | cellular response to interferon-gamma (GO:0071346) | 2.86895526 |
| 99 | negative regulation of humoral immune response (GO:0002921) | 2.83412211 |
| 100 | dendritic cell chemotaxis (GO:0002407) | 2.83032569 |
| 101 | surfactant homeostasis (GO:0043129) | 2.82897555 |
| 102 | response to interleukin-15 (GO:0070672) | 2.82250511 |
| 103 | establishment of endothelial barrier (GO:0061028) | 2.80249046 |
| 104 | negative regulation of myotube differentiation (GO:0010832) | 2.78394943 |
| 105 | tissue homeostasis (GO:0001894) | 2.77939497 |
| 106 | B cell proliferation (GO:0042100) | 2.77130277 |
| 107 | negative regulation of protein activation cascade (GO:2000258) | 2.76437485 |
| 108 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.75861105 |
| 109 | detection of external biotic stimulus (GO:0098581) | 2.74963833 |
| 110 | wound healing, spreading of epidermal cells (GO:0035313) | 2.73428676 |
| 111 | response to interferon-gamma (GO:0034341) | 2.73313885 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 2.69650276 |
| 113 | negative thymic T cell selection (GO:0045060) | 2.67652425 |
| 114 | regulation of T cell tolerance induction (GO:0002664) | 2.65661134 |
| 115 | B cell mediated immunity (GO:0019724) | 2.62692477 |
| 116 | response to unfolded protein (GO:0006986) | 2.62471052 |
| 117 | regulation of regulatory T cell differentiation (GO:0045589) | 2.61858318 |
| 118 | virion attachment to host cell (GO:0019062) | 2.61540192 |
| 119 | adhesion of symbiont to host cell (GO:0044650) | 2.61540192 |
| 120 | production of molecular mediator of immune response (GO:0002440) | 2.60795466 |
| 121 | defense response to Gram-negative bacterium (GO:0050829) | 2.55762565 |
| 122 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.55435884 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.55322163 |
| 124 | protein-chromophore linkage (GO:0018298) | 2.54940631 |
| 125 | fucose metabolic process (GO:0006004) | 2.54783912 |
| 126 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.53922748 |
| 127 | sialylation (GO:0097503) | 2.53059284 |
| 128 | regulation of tolerance induction (GO:0002643) | 2.52987759 |
| 129 | thymic T cell selection (GO:0045061) | 2.51047015 |
| 130 | interferon-gamma secretion (GO:0072643) | 2.50803775 |
| 131 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.50070113 |
| 132 | NIK/NF-kappaB signaling (GO:0038061) | 2.50029661 |
| 133 | negative regulation of mononuclear cell proliferation (GO:0032945) | 2.49660031 |
| 134 | negative regulation of lymphocyte proliferation (GO:0050672) | 2.49660031 |
| 135 | peptide catabolic process (GO:0043171) | 2.48585665 |
| 136 | cellular response to interleukin-15 (GO:0071350) | 2.48222829 |
| 137 | mature B cell differentiation involved in immune response (GO:0002313) | 2.47790478 |
| 138 | regulation of Rho protein signal transduction (GO:0035023) | 2.47572856 |
| 139 | dendritic cell migration (GO:0036336) | 2.45651368 |
| 140 | B cell homeostasis (GO:0001782) | 2.45394389 |
| 141 | angiotensin maturation (GO:0002003) | 2.45033819 |
| 142 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.44974661 |
| 143 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.44863829 |
| 144 | regulation of superoxide anion generation (GO:0032928) | 2.43565630 |
| 145 | sequestering of metal ion (GO:0051238) | 2.43369232 |
| 146 | positive regulation of pseudopodium assembly (GO:0031274) | 2.43236876 |
| 147 | COPII vesicle coating (GO:0048208) | 2.41153310 |
| 148 | positive regulation of B cell activation (GO:0050871) | 2.41045901 |
| 149 | myeloid dendritic cell activation (GO:0001773) | 2.40178042 |
| 150 | positive regulation of T cell migration (GO:2000406) | 2.37844022 |
| 151 | T-helper 1 type immune response (GO:0042088) | 2.34759191 |
| 152 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.34201906 |
| 153 | positive regulation of chemokine secretion (GO:0090197) | 2.33267487 |
| 154 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.32560475 |
| 155 | positive regulation of tolerance induction (GO:0002645) | 2.32061183 |
| 156 | cellular extravasation (GO:0045123) | 2.31596597 |
| 157 | regulation of chemokine secretion (GO:0090196) | 2.31465113 |
| 158 | detection of biotic stimulus (GO:0009595) | 2.30658351 |
| 159 | regulation of T cell migration (GO:2000404) | 2.28999462 |
| 160 | regulation of complement activation (GO:0030449) | 2.27483348 |
| 161 | negative regulation of bone resorption (GO:0045779) | 2.27143468 |
| 162 | eosinophil chemotaxis (GO:0048245) | 2.25785383 |
| 163 | regulation of vitamin metabolic process (GO:0030656) | 2.24281870 |
| 164 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.22893281 |
| 165 | negative regulation of innate immune response (GO:0045824) | 2.22827116 |
| 166 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.22613242 |
| 167 | response to interferon-beta (GO:0035456) | 2.20986118 |
| 168 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.20192913 |
| 169 | regulation of necrotic cell death (GO:0010939) | 2.19917074 |
| 170 | regulation of macrophage chemotaxis (GO:0010758) | 2.19556273 |
| 171 | complement activation, classical pathway (GO:0006958) | 19.7284374 |
| 172 | complement activation (GO:0006956) | 15.1765049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.52045614 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.69534528 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.41641836 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.02721025 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.99682172 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.96879299 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.81644203 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.52989662 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.46800433 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.28135549 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.11432327 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.99154577 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.85604976 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.75260669 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.74722673 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.73518488 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.72478799 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71194598 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.52197770 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.49955256 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.47662185 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.38184948 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.19813905 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.18993696 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.18863996 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.16771885 |
| 27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.15198966 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06964117 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.03882777 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00940252 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00707329 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.96120673 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.93702865 |
| 34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.91873566 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.91377044 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.90072328 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89146183 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84275139 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81003115 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.80800557 |
| 41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.70271182 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66440214 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61966556 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58983657 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56368506 |
| 46 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.55473312 |
| 47 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.54986388 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54000876 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.53646237 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52199444 |
| 51 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.51783918 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49266013 |
| 53 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38487285 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37593060 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33446672 |
| 56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33265721 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.33027594 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32465080 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.31567917 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29836109 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28879617 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26248453 |
| 63 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25364936 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22641944 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22519288 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22304426 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19702150 |
| 68 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18710906 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18492254 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18075255 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17749411 |
| 72 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.17216696 |
| 73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.17211619 |
| 74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15524911 |
| 75 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13257531 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13084272 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11497829 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11402419 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09845866 |
| 80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09420259 |
| 81 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09337880 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08324510 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07587860 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07315614 |
| 85 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06620017 |
| 86 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06107820 |
| 87 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05004424 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04625848 |
| 89 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.03764571 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03261597 |
| 91 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02812292 |
| 92 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02746685 |
| 93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02669778 |
| 94 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98405287 |
| 95 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98290489 |
| 96 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98290489 |
| 97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97931781 |
| 98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97775108 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97728452 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97464580 |
| 101 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.96643554 |
| 102 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96593854 |
| 103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96593854 |
| 104 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95995614 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95041962 |
| 106 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91691030 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90988297 |
| 108 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90295958 |
| 109 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89242649 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89215780 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88946207 |
| 112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88734499 |
| 113 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88357022 |
| 114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87870880 |
| 115 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87262689 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87241647 |
| 117 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86463718 |
| 118 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86372857 |
| 119 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85926745 |
| 120 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85800150 |
| 121 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.85365447 |
| 122 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84430836 |
| 123 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83845035 |
| 124 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83187277 |
| 125 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.82835205 |
| 126 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82654461 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81768681 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81325196 |
| 129 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80642441 |
| 130 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80329255 |
| 131 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.80297991 |
| 132 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79756267 |
| 133 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.79300819 |
| 134 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79250184 |
| 135 | GATA3_26560356_Chip-Seq_TH1_Human | 0.76479498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 6.09301761 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.82594647 |
| 3 | MP0003724_increased_susceptibility_to | 4.58294191 |
| 4 | MP0001800_abnormal_humoral_immune | 4.30973895 |
| 5 | MP0005387_immune_system_phenotype | 3.58408016 |
| 6 | MP0001790_abnormal_immune_system | 3.58408016 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 3.34638375 |
| 8 | MP0003300_gastrointestinal_ulcer | 3.29530850 |
| 9 | MP0002452_abnormal_antigen_presenting | 3.16138621 |
| 10 | MP0005275_abnormal_skin_tensile | 2.81754271 |
| 11 | MP0005671_abnormal_response_to | 2.75983556 |
| 12 | MP0002723_abnormal_immune_serum | 2.60175991 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.49178320 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.47631116 |
| 15 | MP0001819_abnormal_immune_cell | 2.43111986 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.38403126 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.36072920 |
| 18 | MP0000716_abnormal_immune_system | 2.32063623 |
| 19 | MP0002398_abnormal_bone_marrow | 2.26065573 |
| 20 | MP0000685_abnormal_immune_system | 2.22384722 |
| 21 | MP0008438_abnormal_cutaneous_collagen | 2.21592488 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.03637913 |
| 23 | MP0003436_decreased_susceptibility_to | 2.03021526 |
| 24 | MP0005025_abnormal_response_to | 1.97188147 |
| 25 | MP0005166_decreased_susceptibility_to | 1.96897586 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.91536562 |
| 27 | MP0001873_stomach_inflammation | 1.91263436 |
| 28 | MP0002429_abnormal_blood_cell | 1.85672982 |
| 29 | MP0005503_abnormal_tendon_morphology | 1.85334872 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 1.77105850 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.74561690 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.69304802 |
| 33 | MP0006054_spinal_hemorrhage | 1.66011970 |
| 34 | MP0004510_myositis | 1.64967270 |
| 35 | MP0001958_emphysema | 1.61267544 |
| 36 | MP0003448_altered_tumor_morphology | 1.59944118 |
| 37 | MP0002419_abnormal_innate_immunity | 1.59615600 |
| 38 | MP0004947_skin_inflammation | 1.57257016 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.55007600 |
| 40 | MP0002722_abnormal_immune_system | 1.53578521 |
| 41 | MP0008004_abnormal_stomach_pH | 1.48933876 |
| 42 | MP0002006_tumorigenesis | 1.47625780 |
| 43 | MP0003045_fibrosis | 1.41241073 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.40761657 |
| 45 | MP0003279_aneurysm | 1.39445030 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.38967149 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.38251155 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.37515750 |
| 49 | MP0002405_respiratory_system_inflammati | 1.30143032 |
| 50 | MP0005388_respiratory_system_phenotype | 1.29654045 |
| 51 | MP0002133_abnormal_respiratory_system | 1.29654045 |
| 52 | MP0004782_abnormal_surfactant_physiolog | 1.25189215 |
| 53 | MP0002796_impaired_skin_barrier | 1.23904041 |
| 54 | MP0005310_abnormal_salivary_gland | 1.23362344 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.23276816 |
| 56 | MP0000343_altered_response_to | 1.20790322 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.20414663 |
| 58 | MP0002933_joint_inflammation | 1.19334953 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.18159288 |
| 60 | MP0000858_altered_metastatic_potential | 1.16500511 |
| 61 | MP0003828_pulmonary_edema | 1.16225000 |
| 62 | MP0009764_decreased_sensitivity_to | 1.15587068 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.15526601 |
| 64 | MP0005360_urolithiasis | 1.14936249 |
| 65 | MP0005164_abnormal_response_to | 1.14788525 |
| 66 | MP0001663_abnormal_digestive_system | 1.12568255 |
| 67 | MP0004858_abnormal_nervous_system | 1.11965825 |
| 68 | MP0005390_skeleton_phenotype | 1.09359704 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.08757668 |
| 70 | MP0002136_abnormal_kidney_physiology | 1.08164704 |
| 71 | MP0000920_abnormal_myelination | 1.07691802 |
| 72 | MP0003091_abnormal_cell_migration | 1.06772716 |
| 73 | MP0002168_other_aberrant_phenotype | 1.06629210 |
| 74 | MP0009785_altered_susceptibility_to | 1.05274836 |
| 75 | MP0005076_abnormal_cell_differentiation | 1.03790421 |
| 76 | MP0003868_abnormal_feces_composition | 1.03129046 |
| 77 | MP0008872_abnormal_physiological_respon | 1.02554116 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 1.01163414 |
| 79 | MP0002998_abnormal_bone_remodeling | 1.00215892 |
| 80 | MP0008961_abnormal_basal_metabolism | 0.98967325 |
| 81 | MP0002060_abnormal_skin_morphology | 0.98865448 |
| 82 | MP0002254_reproductive_system_inflammat | 0.98662533 |
| 83 | MP0000733_abnormal_muscle_development | 0.98410221 |
| 84 | MP0008995_early_reproductive_senescence | 0.96962634 |
| 85 | MP0000249_abnormal_blood_vessel | 0.96060015 |
| 86 | MP0005409_darkened_coat_color | 0.95989063 |
| 87 | MP0008569_lethality_at_weaning | 0.95947957 |
| 88 | MP0010678_abnormal_skin_adnexa | 0.93631243 |
| 89 | MP0000703_abnormal_thymus_morphology | 0.92577252 |
| 90 | MP0005165_increased_susceptibility_to | 0.91328886 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.90571589 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.90311060 |
| 93 | MP0003866_abnormal_defecation | 0.90304675 |
| 94 | MP0005058_abnormal_lysosome_morphology | 0.89888096 |
| 95 | MP0008260_abnormal_autophagy | 0.89109638 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.88639229 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 0.87416359 |
| 98 | MP0003075_altered_response_to | 0.85350665 |
| 99 | MP0005464_abnormal_platelet_physiology | 0.82578977 |
| 100 | MP0001853_heart_inflammation | 0.82096958 |
| 101 | MP0009278_abnormal_bone_marrow | 0.82005043 |
| 102 | MP0006082_CNS_inflammation | 0.81667995 |
| 103 | MP0001177_atelectasis | 0.80375376 |
| 104 | MP0002019_abnormal_tumor_incidence | 0.79296051 |
| 105 | MP0000609_abnormal_liver_physiology | 0.78882393 |
| 106 | MP0003795_abnormal_bone_structure | 0.78217324 |
| 107 | MP0009840_abnormal_foam_cell | 0.77289224 |
| 108 | MP0005381_digestive/alimentary_phenotyp | 0.77132029 |
| 109 | MP0001944_abnormal_pancreas_morphology | 0.76517203 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.75458789 |
| 111 | MP0001919_abnormal_reproductive_system | 0.75327236 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.74217585 |
| 113 | MP0008469_abnormal_protein_level | 0.72996932 |
| 114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72236641 |
| 115 | MP0002896_abnormal_bone_mineralization | 0.72220287 |
| 116 | MP0000003_abnormal_adipose_tissue | 0.71044679 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.71041418 |
| 118 | MP0005451_abnormal_body_composition | 0.71007171 |
| 119 | MP0003690_abnormal_glial_cell | 0.70777545 |
| 120 | MP0001542_abnormal_bone_strength | 0.70660724 |
| 121 | MP0003329_amyloid_beta_deposits | 0.70113851 |
| 122 | MP0004808_abnormal_hematopoietic_stem | 0.69658146 |
| 123 | MP0000490_abnormal_crypts_of | 0.68353343 |
| 124 | MP0001666_abnormal_nutrient_absorption | 0.66093723 |
| 125 | MP0005023_abnormal_wound_healing | 0.64971290 |
| 126 | MP0001881_abnormal_mammary_gland | 0.64773621 |
| 127 | MP0009046_muscle_twitch | 0.64525879 |
| 128 | MP0001851_eye_inflammation | 0.64355852 |
| 129 | MP0000477_abnormal_intestine_morphology | 0.63415873 |
| 130 | MP0000604_amyloidosis | 0.62447480 |
| 131 | MP0008874_decreased_physiological_sensi | 0.61001564 |
| 132 | MP0003656_abnormal_erythrocyte_physiolo | 0.60676902 |
| 133 | MP0002909_abnormal_adrenal_gland | 0.59224346 |
| 134 | MP0001348_abnormal_lacrimal_gland | 0.57094608 |
| 135 | MP0001191_abnormal_skin_condition | 0.54771935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 8.65806391 |
| 2 | B lymphocytopenia (HP:0010976) | 7.92621363 |
| 3 | Abnormality of B cell number (HP:0010975) | 7.92621363 |
| 4 | Colitis (HP:0002583) | 7.69456461 |
| 5 | Prostate neoplasm (HP:0100787) | 6.96205129 |
| 6 | Recurrent sinusitis (HP:0011108) | 6.52698064 |
| 7 | Cellulitis (HP:0100658) | 6.18570659 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.94208552 |
| 9 | Recurrent bronchitis (HP:0002837) | 5.92842550 |
| 10 | Interstitial pulmonary disease (HP:0006530) | 5.87685777 |
| 11 | Inflammation of the large intestine (HP:0002037) | 5.69668730 |
| 12 | Papilloma (HP:0012740) | 5.53598330 |
| 13 | Verrucae (HP:0200043) | 5.53598330 |
| 14 | Recurrent viral infections (HP:0004429) | 5.50018543 |
| 15 | Gastrointestinal inflammation (HP:0004386) | 5.47413298 |
| 16 | IgM deficiency (HP:0002850) | 4.86849037 |
| 17 | Gastrointestinal stroma tumor (HP:0100723) | 4.82377483 |
| 18 | Chronic otitis media (HP:0000389) | 4.61307529 |
| 19 | Abnormality of the prostate (HP:0008775) | 4.56309530 |
| 20 | Meningitis (HP:0001287) | 4.38868661 |
| 21 | Recurrent pneumonia (HP:0006532) | 4.22112740 |
| 22 | Bronchitis (HP:0012387) | 4.09635192 |
| 23 | Abnormality of complement system (HP:0005339) | 4.03130879 |
| 24 | Osteomyelitis (HP:0002754) | 3.96996442 |
| 25 | Complement deficiency (HP:0004431) | 3.79787811 |
| 26 | Alopecia of scalp (HP:0002293) | 3.74521269 |
| 27 | Glomerulonephritis (HP:0000099) | 3.72413796 |
| 28 | Malnutrition (HP:0004395) | 3.66599990 |
| 29 | Emphysema (HP:0002097) | 3.55813254 |
| 30 | Chronic sinusitis (HP:0011109) | 3.52476917 |
| 31 | Recurrent otitis media (HP:0000403) | 3.41588929 |
| 32 | Recurrent lower respiratory tract infections (HP:0002783) | 3.40849011 |
| 33 | Leukocytosis (HP:0001974) | 3.34191971 |
| 34 | Restrictive lung disease (HP:0002091) | 3.20620800 |
| 35 | Nephritis (HP:0000123) | 3.18436849 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 3.16913017 |
| 37 | Premature loss of primary teeth (HP:0006323) | 3.04169708 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 3.01627489 |
| 39 | Sepsis (HP:0100806) | 2.99183512 |
| 40 | Chronic diarrhea (HP:0002028) | 2.92435880 |
| 41 | Nasal polyposis (HP:0100582) | 2.90033153 |
| 42 | Panhypogammaglobulinemia (HP:0003139) | 2.88661315 |
| 43 | IgA deficiency (HP:0002720) | 2.86966113 |
| 44 | Bronchiectasis (HP:0002110) | 2.84354491 |
| 45 | Gingivitis (HP:0000230) | 2.82566433 |
| 46 | Skin rash (HP:0000988) | 2.80214027 |
| 47 | Vasculitis (HP:0002633) | 2.78870370 |
| 48 | Right ventricular cardiomyopathy (HP:0011663) | 2.78281505 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.73685126 |
| 50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.64203151 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.59432280 |
| 52 | Abnormality of male internal genitalia (HP:0000022) | 2.59057289 |
| 53 | Metaphyseal cupping (HP:0003021) | 2.57830527 |
| 54 | Neoplasm of the lung (HP:0100526) | 2.54708432 |
| 55 | Urticaria (HP:0001025) | 2.54246800 |
| 56 | Thick nail (HP:0001805) | 2.47848119 |
| 57 | Atrophic scars (HP:0001075) | 2.46689731 |
| 58 | Lymphopenia (HP:0001888) | 2.42918414 |
| 59 | Thyroiditis (HP:0100646) | 2.40048429 |
| 60 | Fragile skin (HP:0001030) | 2.39040608 |
| 61 | Increased IgE level (HP:0003212) | 2.38811458 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.38264270 |
| 63 | Orchitis (HP:0100796) | 2.34976947 |
| 64 | Periodontitis (HP:0000704) | 2.34308045 |
| 65 | Mitral stenosis (HP:0001718) | 2.31692705 |
| 66 | Villous atrophy (HP:0011473) | 2.30420369 |
| 67 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.30420369 |
| 68 | Small epiphyses (HP:0010585) | 2.29646406 |
| 69 | Eczematoid dermatitis (HP:0000976) | 2.28984065 |
| 70 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.28870566 |
| 71 | IgG deficiency (HP:0004315) | 2.26131475 |
| 72 | Aortic dissection (HP:0002647) | 2.25502976 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.16685394 |
| 74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.16685394 |
| 75 | Neoplasm of the respiratory system (HP:0100606) | 2.16464125 |
| 76 | Recurrent abscess formation (HP:0002722) | 2.16215097 |
| 77 | Xerostomia (HP:0000217) | 2.14627876 |
| 78 | Ankyloglossia (HP:0010296) | 2.12385769 |
| 79 | Abnormality of T cells (HP:0002843) | 2.11567322 |
| 80 | Skin ulcer (HP:0200042) | 2.10052058 |
| 81 | Pulmonary infiltrates (HP:0002113) | 2.08850841 |
| 82 | Viral hepatitis (HP:0006562) | 2.08549572 |
| 83 | Hypermelanotic macule (HP:0001034) | 2.05728066 |
| 84 | Hematochezia (HP:0002573) | 2.05255335 |
| 85 | Peritonitis (HP:0002586) | 2.05028146 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 2.04959953 |
| 87 | Recurrent bacterial skin infections (HP:0005406) | 2.04207209 |
| 88 | Deep venous thrombosis (HP:0002625) | 2.04180072 |
| 89 | Dehydration (HP:0001944) | 2.03747217 |
| 90 | Recurrent skin infections (HP:0001581) | 2.03695081 |
| 91 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.01760516 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00507853 |
| 93 | Cerebral aneurysm (HP:0004944) | 2.00414515 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 1.99988270 |
| 95 | Hyperactive renin-angiotensin system (HP:0000841) | 1.98080980 |
| 96 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94494435 |
| 97 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.94119445 |
| 98 | Recurrent cutaneous fungal infections (HP:0011370) | 1.94043084 |
| 99 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.94043084 |
| 100 | Retrobulbar optic neuritis (HP:0100654) | 1.93790944 |
| 101 | Optic neuritis (HP:0100653) | 1.93790944 |
| 102 | Pustule (HP:0200039) | 1.90325728 |
| 103 | Autoimmune thrombocytopenia (HP:0001973) | 1.88666466 |
| 104 | Flat acetabular roof (HP:0003180) | 1.87809345 |
| 105 | Purpura (HP:0000979) | 1.87684443 |
| 106 | Conjunctival telangiectasia (HP:0000524) | 1.87522813 |
| 107 | Cheilitis (HP:0100825) | 1.84659069 |
| 108 | Tachypnea (HP:0002789) | 1.84540770 |
| 109 | Abnormal hair laboratory examination (HP:0003328) | 1.82606316 |
| 110 | Abnormality of the fingertips (HP:0001211) | 1.79524522 |
| 111 | Macroorchidism (HP:0000053) | 1.76648218 |
| 112 | Mediastinal lymphadenopathy (HP:0100721) | 1.76127445 |
| 113 | T lymphocytopenia (HP:0005403) | 1.74349623 |
| 114 | Abnormality of T cell number (HP:0011839) | 1.72971776 |
| 115 | Ulnar bowing (HP:0003031) | 1.71660318 |
| 116 | Pulmonary embolism (HP:0002204) | 1.70918068 |
| 117 | Polycythemia (HP:0001901) | 1.70533386 |
| 118 | Neutropenia (HP:0001875) | 1.65003273 |
| 119 | Vacuolated lymphocytes (HP:0001922) | 1.64613079 |
| 120 | Chest pain (HP:0100749) | 1.64518622 |
| 121 | Supranuclear gaze palsy (HP:0000605) | 1.64022023 |
| 122 | Arthralgia (HP:0002829) | 1.63649025 |
| 123 | Abnormal foot bone ossification (HP:0010675) | 1.61538840 |
| 124 | Flattened epiphyses (HP:0003071) | 1.56388690 |
| 125 | Abnormality of the lumbar spine (HP:0100712) | 1.55486915 |
| 126 | Myocardial infarction (HP:0001658) | 1.51338309 |
| 127 | Obstructive lung disease (HP:0006536) | 1.50583018 |
| 128 | Chronic obstructive pulmonary disease (HP:0006510) | 1.50583018 |
| 129 | Hemoptysis (HP:0002105) | 1.49423145 |
| 130 | Premature skin wrinkling (HP:0100678) | 1.49010487 |
| 131 | Cervical subluxation (HP:0003308) | 1.48291569 |
| 132 | Hepatitis (HP:0012115) | 1.48177211 |
| 133 | Abnormality of the intrinsic pathway (HP:0010989) | 1.47927732 |
| 134 | Back pain (HP:0003418) | 1.47659639 |
| 135 | Mucosal telangiectasiae (HP:0100579) | 1.45235015 |
| 136 | Aortic aneurysm (HP:0004942) | 1.45192174 |
| 137 | Myositis (HP:0100614) | 1.43053194 |
| 138 | Abnormal tarsal ossification (HP:0008369) | 1.42911373 |
| 139 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.41698872 |
| 140 | Thrombocytosis (HP:0001894) | 1.41089939 |
| 141 | Ulnar deviation of the wrist (HP:0003049) | 1.40921610 |
| 142 | Abnormality of macrophages (HP:0004311) | 1.40585460 |
| 143 | Cerebral inclusion bodies (HP:0100314) | 1.40425051 |
| 144 | Abnormality of the common coagulation pathway (HP:0010990) | 1.39743945 |
| 145 | Leukopenia (HP:0001882) | 1.37199769 |
| 146 | Subacute progressive viral hepatitis (HP:0006572) | 1.36471931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 7.05377587 |
| 2 | MAP4K1 | 4.83973679 |
| 3 | TAOK3 | 4.21655145 |
| 4 | PDK2 | 3.29845231 |
| 5 | MST1R | 3.26821271 |
| 6 | TYK2 | 2.88551566 |
| 7 | RIPK4 | 2.87552116 |
| 8 | GRK6 | 2.69435785 |
| 9 | MAP3K10 | 2.68127377 |
| 10 | SIK2 | 2.24615900 |
| 11 | PRPF4B | 2.14443495 |
| 12 | BLK | 2.13365438 |
| 13 | NME2 | 2.12077893 |
| 14 | JAK1 | 2.00210091 |
| 15 | SYK | 1.95948614 |
| 16 | KIT | 1.89069406 |
| 17 | CDC42BPA | 1.82776006 |
| 18 | CSF1R | 1.80420045 |
| 19 | MAP3K14 | 1.72998850 |
| 20 | FGFR4 | 1.71208478 |
| 21 | TGFBR2 | 1.67908761 |
| 22 | LRRK2 | 1.64956875 |
| 23 | EPHB1 | 1.51955096 |
| 24 | PIK3CA | 1.47147797 |
| 25 | HIPK2 | 1.44486350 |
| 26 | IRAK1 | 1.39070561 |
| 27 | IRAK3 | 1.38424013 |
| 28 | PRKCH | 1.38072236 |
| 29 | STK10 | 1.35546139 |
| 30 | FER | 1.31251976 |
| 31 | FGFR3 | 1.29961670 |
| 32 | EIF2AK3 | 1.29811903 |
| 33 | MAP3K13 | 1.27805657 |
| 34 | BTK | 1.24850055 |
| 35 | MET | 1.21262102 |
| 36 | BMPR2 | 1.20061229 |
| 37 | TGFBR1 | 1.17811968 |
| 38 | TBK1 | 1.12912821 |
| 39 | STK24 | 1.12765698 |
| 40 | NEK9 | 1.11876468 |
| 41 | ITK | 1.11578472 |
| 42 | NEK6 | 1.09948401 |
| 43 | JAK3 | 1.09431345 |
| 44 | HCK | 1.08406596 |
| 45 | MAP3K1 | 1.07382295 |
| 46 | NLK | 1.05971858 |
| 47 | FES | 1.05931138 |
| 48 | TRIB3 | 1.05406606 |
| 49 | EPHA2 | 1.05340180 |
| 50 | IKBKE | 1.03947562 |
| 51 | MAP3K9 | 1.00215317 |
| 52 | KSR2 | 0.94212870 |
| 53 | PIK3CG | 0.92933830 |
| 54 | LYN | 0.89365224 |
| 55 | ALK | 0.87582477 |
| 56 | DDR2 | 0.87113898 |
| 57 | CDK12 | 0.84997634 |
| 58 | SIK3 | 0.84597186 |
| 59 | SIK1 | 0.84053145 |
| 60 | MYLK | 0.82883935 |
| 61 | CSK | 0.81919527 |
| 62 | MAP3K6 | 0.81249413 |
| 63 | IRAK4 | 0.80105584 |
| 64 | PRKCQ | 0.80058852 |
| 65 | EPHB2 | 0.80046814 |
| 66 | MAP3K3 | 0.79134530 |
| 67 | PDK1 | 0.78996708 |
| 68 | ACVR1B | 0.77020854 |
| 69 | PRKD1 | 0.75901680 |
| 70 | LMTK2 | 0.75687876 |
| 71 | MAP3K7 | 0.75290473 |
| 72 | YES1 | 0.75222505 |
| 73 | JAK2 | 0.74420417 |
| 74 | PKN2 | 0.73660968 |
| 75 | RET | 0.72308795 |
| 76 | EEF2K | 0.71945698 |
| 77 | BMX | 0.69599647 |
| 78 | PIM1 | 0.69185321 |
| 79 | LCK | 0.67425381 |
| 80 | MAPK7 | 0.66677135 |
| 81 | MAPKAPK3 | 0.66240671 |
| 82 | TEC | 0.65536191 |
| 83 | IKBKB | 0.64729874 |
| 84 | PRKG2 | 0.61525309 |
| 85 | FYN | 0.60927297 |
| 86 | PTK6 | 0.59941881 |
| 87 | PKN1 | 0.59553426 |
| 88 | PDPK1 | 0.59499375 |
| 89 | SMG1 | 0.58936650 |
| 90 | FGFR2 | 0.58542110 |
| 91 | EPHA3 | 0.57098124 |
| 92 | MAP2K3 | 0.55821814 |
| 93 | PAK4 | 0.55629791 |
| 94 | CAMK1G | 0.54993370 |
| 95 | TAOK1 | 0.53367957 |
| 96 | MST4 | 0.53309131 |
| 97 | PRKD2 | 0.52289760 |
| 98 | DMPK | 0.49096291 |
| 99 | TIE1 | 0.48060092 |
| 100 | CSNK1A1L | 0.47775232 |
| 101 | SGK3 | 0.47487143 |
| 102 | STK39 | 0.46565523 |
| 103 | MAPKAPK2 | 0.45688945 |
| 104 | RIPK1 | 0.45682278 |
| 105 | MAP2K2 | 0.44963046 |
| 106 | IGF1R | 0.44696341 |
| 107 | GRK5 | 0.42984356 |
| 108 | EGFR | 0.42396355 |
| 109 | TTN | 0.41169264 |
| 110 | WNK1 | 0.40444851 |
| 111 | MAPK11 | 0.40185237 |
| 112 | PDGFRB | 0.39623472 |
| 113 | ABL1 | 0.38614623 |
| 114 | CLK1 | 0.38378961 |
| 115 | BCKDK | 0.37571728 |
| 116 | MAPK12 | 0.35553073 |
| 117 | CDK6 | 0.35536674 |
| 118 | MAPK4 | 0.35392971 |
| 119 | OXSR1 | 0.34087356 |
| 120 | FLT3 | 0.33820976 |
| 121 | PDGFRA | 0.33599258 |
| 122 | NEK2 | 0.32686637 |
| 123 | MARK3 | 0.31657534 |
| 124 | BRD4 | 0.30946301 |
| 125 | INSR | 0.29854161 |
| 126 | CSNK1G3 | 0.29737002 |
| 127 | TXK | 0.29570676 |
| 128 | FRK | 0.29145208 |
| 129 | MATK | 0.28795358 |
| 130 | ZAP70 | 0.27880664 |
| 131 | CSNK1G2 | 0.26273715 |
| 132 | CHUK | 0.25888950 |
| 133 | MAP3K2 | 0.25750401 |
| 134 | PRKCD | 0.25346612 |
| 135 | MARK2 | 0.24896121 |
| 136 | UHMK1 | 0.23077378 |
| 137 | CDK9 | 0.22395684 |
| 138 | FGR | 0.21944483 |
| 139 | SRC | 0.20184294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 7.28010401 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.42181339 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.01792634 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.20724642 |
| 5 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 3.06367379 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.82335294 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.73607077 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.32204579 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32076902 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.98394592 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.74815859 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.70795544 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61656083 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.60322656 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.56704555 |
| 16 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.47327874 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46075350 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41795697 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39386593 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37671513 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32641621 |
| 22 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29181356 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.24758853 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23146529 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21745445 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.18180359 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16343091 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15288362 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06235718 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05521538 |
| 31 | Amoebiasis_Homo sapiens_hsa05146 | 1.00975825 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00395074 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.96110341 |
| 34 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94714824 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 0.94417953 |
| 36 | Malaria_Homo sapiens_hsa05144 | 0.94094190 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93030323 |
| 38 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.92529768 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91477733 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91174065 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 0.91157983 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90128674 |
| 43 | Measles_Homo sapiens_hsa05162 | 0.88008266 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86610085 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85864071 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85179984 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84739954 |
| 48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84457238 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84186674 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82839981 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82124637 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.81080336 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 0.79405137 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77279956 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.75458495 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75295595 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.73708940 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73388178 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73148991 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72048875 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69930747 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69230144 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68596993 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68531480 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 0.67641562 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67211541 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.67078257 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65822894 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.64541483 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.63792802 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63707593 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63585638 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63137527 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62847686 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62524963 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.62327498 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62191728 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61844816 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61590270 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59659785 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.59572380 |
| 82 | Allograft rejection_Homo sapiens_hsa05330 | 0.57442759 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57379952 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57169732 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55727240 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55516595 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55387169 |
| 88 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54180781 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53622388 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52512197 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.51011791 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50955336 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.49936040 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49884704 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49393219 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.49176354 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48278005 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.47712911 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45502514 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44363105 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44302038 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43230019 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42790074 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41683544 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41493231 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41479106 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40854565 |
| 108 | Cocaine addiction_Homo sapiens_hsa05030 | 0.40633322 |
| 109 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40441830 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39494282 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39036527 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.38944678 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38295994 |
| 114 | Insulin secretion_Homo sapiens_hsa04911 | 0.37327129 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37102227 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37064476 |
| 117 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36915084 |
| 118 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36901169 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35667291 |
| 120 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34981436 |
| 121 | Lysosome_Homo sapiens_hsa04142 | 0.34091809 |
| 122 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33860662 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33478123 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | 0.33419481 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.33369238 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.33354379 |
| 127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32676044 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32254045 |
| 129 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.31567046 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31186294 |
| 131 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31130891 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30965775 |
| 133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30597330 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29360319 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | 0.29359780 |
| 136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28810319 |
| 137 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.27890749 |
| 138 | Circadian entrainment_Homo sapiens_hsa04713 | 0.27628029 |

